Evidence map›Paper›PMID 38071476›Full record

ArticleRNA (New York, N.Y.)2024

Broad variation in response of individual introns to splicing inhibitors in a humanized yeast strain.

Oarteze Hunter, Jason Talkish, Jen Quick-Cleveland, Haller Igel, Asako Tan, Scott Kuersten, Sol Katzman, John Paul Donohue, Melissa S Jurica, Manuel Ares

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Oarteze HunterCenter for Molecular Biology of RNA, University of California, Santa Cruz, California 95064, USA.ORCID 0000-0003-0458-4229
Jason TalkishCenter for Molecular Biology of RNA, University of California, Santa Cruz, California 95064, USA.ORCID 0000-0002-0260-3345
Jen Quick-ClevelandCenter for Molecular Biology of RNA, University of California, Santa Cruz, California 95064, USA.ORCID 0000-0002-4070-8842
Haller IgelCenter for Molecular Biology of RNA, University of California, Santa Cruz, California 95064, USA.ORCID 0000-0001-6468-3128
Asako TanIllumina, Inc., Madison, Wisconsin 53719, USA.
Scott KuerstenIllumina, Inc., Madison, Wisconsin 53719, USA.
Sol KatzmanCenter for Molecular Biology of RNA, University of California, Santa Cruz, California 95064, USA.ORCID 0000-0002-1787-1246
John Paul DonohueCenter for Molecular Biology of RNA, University of California, Santa Cruz, California 95064, USA.ORCID 0000-0002-5497-1940
Melissa S JuricaCenter for Molecular Biology of RNA, University of California, Santa Cruz, California 95064, USA.ORCID 0000-0002-4488-1386
Manuel AresCenter for Molecular Biology of RNA, University of California, Santa Cruz, California 95064, USA ares@ucsc.edu.ORCID 0000-0002-2552-9168
University of California, Santa Cruz · USIllumina (United States) · US

Funding

UNIVERSITY OF CALIFORNIA, SANTA CRUZ IMSD PROGRAMR25GM058903 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI JURICA, MELISSA S · 1999 to 2019
$12.2M
STRUCTURE/FUNCTION OF YEAST SMALL NUCLEAR RNPSR01GM040478 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI ARES, MANUEL · 1988 to 2021
$10.8M
Structure, regulation, and evolution of the splicing machineryR35GM145266 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI Manuel Ares · 2022 to 2026
$2.5M
NIGMS NIH HHS R01 GM040478NIGMS NIH HHS R25 GM058903NIGMS NIH HHS R35 GM145266
6 · The paper itself

Abstract

Intron branchpoint (BP) recognition by the U2 snRNP is a critical step of splicing, vulnerable to recurrent cancer mutations and bacterial natural product inhibitors. The BP binds a conserved pocket in the SF3B1 (human) or Hsh155 (yeast) U2 snRNP protein. Amino acids that line this pocket affect the binding of splicing inhibitors like Pladienolide-B (Plad-B), such that organisms differ in their sensitivity. To study the mechanism of splicing inhibitor action in a simplified system, we modified the naturally Plad-B resistant yeast

Indexed as

Saccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsAmino AcidsHumansIntronsRibonucleoprotein, U2 Small NuclearRNA PrecursorsRNA SplicingSpliceosomesAmino AcidsRibonucleoprotein, U2 Small NuclearRNA PrecursorsSaccharomyces cerevisiae Proteinshumanized yeastintron retentionpre-mRNA accumulationSF3B1splicing inhibitors

Identifiers

PMID38071476
PMCPMC10798247
OpenAlexW4389074464

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.